AAAAAA
Results:
1-12
|
Results: 12
Authors:
Barbui, C
Guaiana, G
Garatini, S
Citation: C. Barbui et al., Regulatory issues in Europe, J CL PSYCH, 21(6), 2001, pp. 545-548
Authors:
Barbui, C
Campomori, A
Mezzalira, L
Lopatriello, S
Da Cas, R
Garattini, S
Citation: C. Barbui et al., Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status, INT CLIN PS, 16(4), 2001, pp. 227-233
Authors:
Pietraru, C
Barbui, C
Poggio, L
Tognoni, G
Citation: C. Pietraru et al., Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database, EUR J CL PH, 57(8), 2001, pp. 605-609
Authors:
Barbui, C
Hotopf, M
Citation: C. Barbui et M. Hotopf, Amitriptyline v. the rest: still the leading antidepressant after 40 yearsof randomised controlled trials, BR J PSYCHI, 178, 2001, pp. 129-144
Authors:
Barbui, C
Hotopf, M
Citation: C. Barbui et M. Hotopf, Forty years of antidepressant drug trials, ACT PSYC SC, 104(2), 2001, pp. 92-95
Authors:
Barbui, C
Violante, A
Garattini, S
Citation: C. Barbui et al., Does placebo help establish equivalence in trials of new antidepressants?, EUR PSYCHIA, 15(4), 2000, pp. 268-273
Authors:
Barbui, C
Citation: C. Barbui, Italy's mad law, ACT PSYC SC, 102(5), 2000, pp. 396-396
Authors:
Barbui, C
D'Avanzo, B
Frattura, L
Saraceno, B
Citation: C. Barbui et al., QUALYOP Project 2: Monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatients, PHARMA D S, 8(5), 1999, pp. 331-337
Authors:
Barbui, C
Campomori, A
D'Avanzo, B
Negri, E
Garattini, S
Citation: C. Barbui et al., Antidepressant drug use in Italy since the introduction of SSRIs: nationaltrends, regional differences and impact on suicide rates, SOC PSY PSY, 34(3), 1999, pp. 152-156
Authors:
Barbui, C
Garattini, S
Citation: C. Barbui et S. Garattini, Clinical trials of new antipsychotics: a critical appraisal, INT CLIN PS, 14(2), 1999, pp. 133-137
Authors:
Alison, P
Amato, U
Angelatos, MP
Arcari, S
Argentiero, I
Balzani, A
Barbagallo, C
Barbui, C
Bertoldin, T
Bianchetti, M
Bonini, D
Bracco, R
Caldarone, D
Callegari, V
Capodieci, B
Caprino, V
Cardamone, G
Di Benedetto, P
Donisi, R
Dramisino, G
Errico, M
Evaristo, P
Falavolti, S
Ferrari, G
Forte, G
Galli, C
Garofalo, A
Giudiceandrea, A
Gracco, F
Grasso, F
Gregorutti, C
Guarnieri, A
Gugliotta, M
Interlandi, G
Karavalaki, I
Laddomada, F
Lieti, M
Liguori, G
Loparco, N
Lorenzetti, MP
Maestra, MR
Mangione, C
Marani, S
Marchetti, AP
Mareschi, N
Mari, L
Marzullo, F
Materzanini, A
Mazzarda, A
Mazze, R
Mazzuia, P
Mengano, A
Musazzi, A
Novello, M
Panza, G
Pappalardo, L
Pardi, G
Pederzoli, L
Pismataro, CP
Primiani, G
Provenzano, S
Punzo, F
Ranieri, L
Raspini, V
Re, E
Ricciardelli, F
Ritacco, A
Rossini, R
Ruggeri, A
Scala, A
Scarani, G
Schneider, MG
Storer, C
Tauriello, A
Terzian, E
Tinagli, A
Tognoni, G
Valletta, M
Yurincic, M
Zuccolo, D
Citation: P. Alison et al., Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy, EUR J CL PH, 55(9), 1999, pp. 685-690
Authors:
D'Avanzo, B
Frattura, L
Barbui, C
Civenti, G
Saraceno, B
Citation: B. D'Avanzo et al., The Qualyop Project 1: Monitoring the dismantlement of Italian public psychiatric hospitals. Characteristics of patients scheduled for discharge, INT J SOC P, 45(2), 1999, pp. 79-92
Risultati:
1-12
|